Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| §102 only | 1 (25%) |
| §112 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VASISTH, VISHAL V | 1 | 72.3% | +33.3% |
| BORALSKY, LUKE ALAN | 1 | 100.0% | +0.0% |
| KIFLE, BRUCK | 1 | 79.2% | +15.9% |
| JARRELL, NOBLE E | 1 | 81.3% | +9.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17451021 | Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof | JARRELL, NOBLE E | 42d overdue |
| 18462373 | PYRIDOPYRIMIDINE-BASED COMPOUND AND APPLICATION THEREOF | BORALSKY, LUKE ALAN | 54d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18245676 | PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | KIFLE, BRUCK | 20d |
| 18695741 | PREPARATION METHOD FOR 1,3-DISUBSTITUTED ALLENE COMPOUND AT ROOM TEMPERATURE BASED ON METAL CARBENE CATALYTIC SYSTEM | VASISTH, VISHAL V | 34d |
| Art Unit | Apps |
|---|---|
| 1624 | 2 |
| 1771 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18695741 | PREPARATION METHOD FOR 1,3-DISUBSTITUTED ALLENE COMPOUND AT ROOM TEMPERATURE BASED ON METAL CARBENE CATALYTIC SYSTEM | VASISTH, VISHAL V | 1771 | §103 | Non-Final OA | 34d | Pending | Mar 26, 2024 |
| 18462373 | PYRIDOPYRIMIDINE-BASED COMPOUND AND APPLICATION THEREOF | BORALSKY, LUKE ALAN | 1624 | §102 | Non-Final OA | 54d | Pending | Sep 06, 2023 |
| 18245676 | PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | KIFLE, BRUCK | 1624 | §112 | Final Rejection | 20d | Pending | Mar 16, 2023 |
| 17451021 | Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof | JARRELL, NOBLE E | 1699 | §103 | Non-Final OA | 42d overdue | Pending | Oct 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial